Combination of | |
---|---|
Testosterone | Androgen |
Dutasteride | 5α-Reductase inhibitor |
Clinical data | |
Other names | Dutasteride/testosterone |
Testosterone/dutasteride is a combination formulation of testosterone, an androgen, and dutasteride, a 5α-reductase inhibitor, which was under development by GlaxoSmithKline for the treatment of hypogonadism (low testosterone levels) in men in the 2000s.[1] It reached phase II clinical trials prior to the discontinuation of its development.[1]